John E. Duda

12.8k citations

61 papers · 8.0k indexed · 2 hit papers · h-index 38

Impact in

Neurology top 0.05%
- Parkinson's Disease Mechanisms and Treatments
- Neurological disorders and treatments
Psychiatry and Mental health top 0.5%
- Dementia and Cognitive Impairment Research

Papers in ⓘ

Neurology 47
- Parkinson's Disease Mechanisms and Treatments 47
- Neurological disorders and treatments 20
- Neurological diseases and metabolism 5
Psychiatry and Mental health 23
- Dementia and Cognitive Impairment Research 16

Co-authors: Daniel Weintraub (38 shared papers)Andrew Siderowf (22 shared papers)Matthew B. Stern (21 shared papers)Howard I. Hurtig (14 shared papers)Virginia M.‐Y. Lee (6 shared papers)Paul J. Moberg (18 shared papers)John Q. Trojanowski (17 shared papers)Benoit I. Giasson (6 shared papers)
Journals: Movement Disorders (7 papers)Neurology (7 papers)Parkinsonism & Related Disorders (7 papers)Journal of Parkinson s Disease (4 papers)Journal of the American Geriatrics Society (2 papers)
Partner nations: United States United Kingdom Canada

In The Last Decade

John E. Duda

61 papers receiving 7.7k citations

Hit Papers

align trajectories log scale

Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease 2009 · 929 citations

Peers

Countries citing papers authored by John E. Duda

Since Specialization

Citations

This map shows the geographic impact of John E. Duda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John E. Duda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John E. Duda more than expected).

Fields of papers citing papers by John E. Duda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John E. Duda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John E. Duda. The network helps show where John E. Duda may publish in the future.

Co-authors

The 25 scholars most cited alongside John E. Duda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John E. Duda Line = papers co-authored together John E. Duda links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 61 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Oxidative Damage Linked to Neurodegeneration by Selective α-Synuclein Nitration in Synucleinopathy Lesions Science ·Benoit I. Giasson, John E. Duda, Ian Murray, Qiping Chen, José M. Souza, Howard I. Hurtig, Harry Ischiropoulos, John Q. Trojanowski, Virginia M.‐Y. Lee Hit paper breakdown →	2000	1280
2	Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease Neurology ·Staci Hoops, Sarra Nazem, Andrew Siderowf, John E. Duda, Sharon X. Xie, M. B. Stern, Daniel Weintraub Hit paper breakdown →	2009	929
3	Association of Dopamine Agonist Use With Impulse Control Disorders in Parkinson Disease Archives of Neurology ·Daniel Weintraub, Andrew Siderowf, Marc N. Potenza, Joseph S. Goveas, Knashawn H. Morales, John E. Duda, Paul J. Moberg, Matthew B. Stern	2006	485
4	Validation of the questionnaire for impulsive‐compulsive disorders in Parkinson's disease Movement Disorders ·Daniel Weintraub, Staci Hoops, Judy A. Shea, Kelly E. Lyons, Rajesh Pahwa, Erika Driver‐Dunckley, Charles H. Adler, Marc N. Potenza, Janis M. Miyasaki, Andrew Siderowf, John E. Duda, Howard I. Hurtig, Amy Colcher, Stacy Horn, Matthew B. Stern, Valerie Voon	2009	390
5	Effect of Psychiatric and Other Nonmotor Symptoms on Disability in Parkinson's Disease Journal of the American Geriatrics Society ·Daniel Weintraub, Paul J. Moberg, John E. Duda, Ira R. Katz, Matthew B. Stern	2004	303
6	CSF amyloid β 1-42 predicts cognitive decline in Parkinson disease Neurology ·Andrew Siderowf, Sharon X. Xie, Howard I. Hurtig, Daniel Weintraub, John E. Duda, Alice Chen‐Plotkin, Leslie M. Shaw, Vivianna M. Van Deerlin, John Q. Trojanowski, C. Clark	2010	281
7	Novel antibodies to synuclein show abundant striatal pathology in Lewy body diseases Annals of Neurology ·John E. Duda, Benoit I. Giasson, Meghann E. Mabon, Virginia M.‐Y. Lee, John Q. Trojanowski	2002	260
8	Montreal Cognitive Assessment Performance in Patients with Parkinson's Disease with “Normal” Global Cognition According to Mini‐Mental State Examination Score Journal of the American Geriatrics Society ·Sarra Nazem, Andrew Siderowf, John E. Duda, Tom Ten Have, Amy Colcher, Stacy Horn, Paul J. Moberg, Jayne Wilkinson, Howard I. Hurtig, Matthew B. Stern, Daniel Weintraub	2008	247
9	Neuropathology of synuclein aggregates Journal of Neuroscience Research ·John E. Duda, Virginia M.‐Y. Lee, John Q. Trojanowski	2000	227
10	Widespread Nitration of Pathological Inclusions in Neurodegenerative Synucleinopathies American Journal Of Pathology ·John E. Duda, Benoit I. Giasson, Qiping Chen, Tamar Gur, Howard I. Hurtig, Matthew B. Stern, Steven M. Gollomp, Harry Ischiropoulos, Virginia M.‐Y. Lee, John Q. Trojanowski	2000	226
11	A panel of epitope-specific antibodies detects protein domains distributed throughout human ?-synuclein in lewy bodies of Parkinson's disease Journal of Neuroscience Research ·Benoit I. Giasson, Ross Jakes, Michel Goedert, John E. Duda, Susan Leight, John Q. Trojanowski, V. M.-Y. Lee	2000	193
12	Striatal dopamine transporter imaging correlates with anxiety and depression symptoms in Parkinson's disease. PubMed ·Daniel Weintraub, Andrew B. Newberg, Mark Cary, Andrew Siderowf, Paul J. Moberg, Galit Kleiner‐Fisman, John E. Duda, Matthew B. Stern, David Mozley, Ira R. Katz	2005	191
13	Longitudinal study of normal cognition in Parkinson disease Neurology ·Kara Pigott, Jacqueline Rick, Sharon X. Xie, Howard Hurtig, Alice Chen‐Plotkin, John E. Duda, James F. Morley, Lana M. Chahine, Nabila Dahodwala, Rizwan Akhtar, Andrew Siderowf, John Q. Trojanowski, Daniel Weintraub	2015	188
14	Atomoxetine for depression and other neuropsychiatric symptoms in Parkinson disease Neurology ·Daniel Weintraub, Shahrzad Mavandadi, Euginia Mamikonyan, Andrew Siderowf, John E. Duda, Howard I. Hurtig, Amy Colcher, Sarah Horn, Sarra Nazem, (unknown), M. B. Stern	2010	186
15	Long‐term follow‐up of impulse control disorders in Parkinson's disease Movement Disorders ·Eugenia Mamikonyan, Andrew Siderowf, John E. Duda, Marc N. Potenza, Stacy Horn, Matthew B. Stern, Daniel Weintraub	2007	173
16	Recognition and Treatment of Depression in Parkinson's Disease Journal of Geriatric Psychiatry and Neurology ·Daniel Weintraub, Paul J. Moberg, John E. Duda, Ira R. Katz, Matthew B. Stern	2003	156
17	Alzheimer's disease pattern of brain atrophy predicts cognitive decline in Parkinson's disease Brain ·Daniel Weintraub, Nikolaus Dietz, John E. Duda, David A. Wolk, Jimit Doshi, Sharon X. Xie, Christos Davatzikos, Chris M. Clark, Andrew Siderowf	2011	152
18	Mild cognitive impairment is common in Parkinson's disease patients with normal Mini-Mental State Examination (MMSE) scores Parkinsonism & Related Disorders ·Eugenia Mamikonyan, Paul J. Moberg, Andrew Siderowf, John E. Duda, Tom Ten Have, Howard I. Hurtig, Matthew B. Stern, Daniel Weintraub	2008	146
19	Antidepressant studies in Parkinson's disease: A review and meta‐analysis Movement Disorders ·Daniel Weintraub, Knashawn H. Morales, Paul J. Moberg, Warren B. Bilker, Catherine C. Balderston, John E. Duda, Ira R. Katz, Matthew B. Stern	2005	136
20	Immunohistochemical and Biochemical Studies Demonstrate a Distinct Profile of α-Synuclein Permutations in Multiple System Atrophy Journal of Neuropathology & Experimental Neurology ·John E. Duda, Benoit I. Giasson, Tamar Gur, Thomas J. Montine, David L. Robertson, Italo Biaggioni, Howard I. Hurtig, Matthew B. Stern, Steven M. Gollomp, Murray Grossman, Virginia M.‐Y. Lee, John Q. Trojanowski	2000	129

About John E. Duda

John E. Duda is a scholar working on Neurology, Psychiatry and Mental health, Cognitive Neuroscience, Physiology and Cellular and Molecular Neuroscience, having authored 61 papers that have together received 8.0k indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (47 papers), Neurological disorders and treatments (20 papers), Dementia and Cognitive Impairment Research (16 papers), Alzheimer's disease research and treatments (9 papers), Neurobiology of Language and Bilingualism (9 papers), Neurological diseases and metabolism (5 papers), Obsessive-Compulsive Spectrum Disorders (5 papers) and Olfactory and Sensory Function Studies (4 papers). The work is most often cited by research in Neurology (5.7k citations), Neurology (952 citations), Psychiatry and Mental health (1.6k citations), Cellular and Molecular Neuroscience (1.6k citations) and Physical Therapy, Sports Therapy and Rehabilitation (344 citations). John E. Duda has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Daniel Weintraub, Andrew Siderowf, Matthew B. Stern, Howard I. Hurtig, Virginia M.‐Y. Lee, Paul J. Moberg, John Q. Trojanowski, Benoit I. Giasson, Sharon X. Xie and Sarra Nazem. Their work appears in journals such as Movement Disorders, Neurology, Parkinsonism & Related Disorders, Journal of Parkinson s Disease and Journal of the American Geriatrics Society.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact